Cargando…
Effect of MAO-B Inhibitors on Neurometabolic Profile of Patients Affected by Parkinson Disease: A Proton Magnetic Resonance Spectroscopy Study
Parkinson’s Disease (PD) is the most common neurodegenerative movement disorder whose treatment is symptomatic. No suitable methods for assessing the effects of dopaminergic drugs on disease progression in clinical trials have yet been provided. The aim of this longitudinal study is to evaluate the...
Autores principales: | Bonanno, Lilla, Ciurleo, Rosella, Marino, Silvia, Ruvolo, Claudio, Morabito, Rosa, Bramanti, Alessia, Corallo, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999805/ https://www.ncbi.nlm.nih.gov/pubmed/35407539 http://dx.doi.org/10.3390/jcm11071931 |
Ejemplares similares
-
Longitudinal analysis of brain atrophy in Alzheimer’s disease and frontotemporal dementia
por: Marino, Silvia, et al.
Publicado: (2019) -
Magnetic Resonance Spectroscopy: An In Vivo Molecular Imaging Biomarker for Parkinson's Disease?
por: Ciurleo, Rosella, et al.
Publicado: (2014) -
The impact of SARS-COV2 infection on people in residential care with Parkinson Disease or parkinsonisms: Clinical case series study
por: Sorbera, Chiara, et al.
Publicado: (2021) -
The effect on deep brain stimulation of subthalamic nucleus and dopaminergic treatment in Parkinson disease
por: Lo Buono, Viviana, et al.
Publicado: (2020) -
Functional Evaluation of Awareness in Vegetative and Minimally Conscious State
por: Marino, Silvia, et al.
Publicado: (2017)